Free Trial
NASDAQ:GEHC

GE HealthCare Technologies Q2 2025 Earnings Report

GE HealthCare Technologies logo
$75.96 -0.28 (-0.37%)
Closing price 04:00 PM Eastern
Extended Trading
$75.96 0.00 (0.00%)
As of 04:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GE HealthCare Technologies EPS Results

Actual EPS
N/A
Consensus EPS
$0.91
Beat/Miss
N/A
One Year Ago EPS
N/A

GE HealthCare Technologies Revenue Results

Actual Revenue
N/A
Expected Revenue
$4.96 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

GE HealthCare Technologies Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Wednesday, July 30, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

GE HealthCare Technologies Earnings Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
See More GE HealthCare Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GE HealthCare Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GE HealthCare Technologies and other key companies, straight to your email.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ:GEHC), Inc. (NASDAQ: GEHC) is a global leader in medical technology and life sciences, offering a wide array of products and services designed to improve patient care and streamline clinical workflows. Formed as an independent public company following its separation from General Electric in early 2023, GE HealthCare combines decades of innovation in diagnostic imaging, ultrasound, molecular imaging, and digital health solutions. The company’s mission is to drive precision health by harnessing data, analytics, and advanced technology to deliver better outcomes for patients and providers.

In its diagnostic imaging portfolio, GE HealthCare provides a comprehensive range of modalities, including computed tomography (CT), magnetic resonance imaging (MRI), X-ray, nuclear imaging, and interventional imaging systems. The company’s ultrasound division offers point-of-care and radiology ultrasound systems, as well as contrast imaging and women’s health solutions. Complementing its hardware offerings, GE HealthCare has invested heavily in digital platforms and artificial intelligence, delivering cloud-based software that supports image analysis, workflow optimization, and remote collaboration among healthcare teams.

Beyond medical imaging, GE HealthCare serves the life sciences and cell therapy markets with bioprocessing technologies, single-use systems, and automation platforms. These solutions enable pharmaceutical and biotechnology companies to accelerate drug discovery, large-scale biologics production, and emerging therapies such as cell and gene treatments. By integrating process analytics and digital twins, the company aims to enhance manufacturing efficiency, consistency, and regulatory compliance across research and production environments.

Headquartered in Chicago and operating in more than 140 countries, GE HealthCare is led by President and Chief Executive Officer Kieran Murphy, alongside a diverse executive team with deep industry expertise. The company’s global footprint encompasses research and development centers, manufacturing facilities, and service operations, ensuring localized support for customers in North America, Europe, Asia-Pacific, and emerging markets. With a commitment to sustainability and equitable access to care, GE HealthCare continues to collaborate with healthcare providers, governments, and non-profit organizations to address critical challenges in global health.

View GE HealthCare Technologies Profile

More Earnings Resources from MarketBeat